Maximizing contrast‐to‐noise ratio in ultra‐high resolution peripheral MR angiography using a blood pool agent and parallel imaging

To determine sequence parameters that maximize vascular contrast‐to‐noise (CNR) for ultra‐high resolution equilibrium phase (EP) peripheral imaging for the blood pool agent (BPA) Vasovist.

[1]  C. Catalano,et al.  ECG-gated multi-detector row spiral CT in the assessment of myocardial infarction: correlation with non-invasive angiographic findings , 2005, European Radiology.

[2]  D. Look,et al.  Time Saving in Measurement of NMR and EPR Relaxation Times , 1970 .

[3]  S. F. Quinn,et al.  Aortoiliac occlusive disease in patients with known or suspected peripheral vascular disease: safety and efficacy of gadofosveset-enhanced MR angiography--multicenter comparative phase III study. , 2005, Radiology.

[4]  R. Lauffer,et al.  Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. , 1997, Investigative radiology.

[5]  J. Mintorovitch,et al.  Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths , 2005, Investigative radiology.

[6]  E R McVeigh,et al.  The effect of high performance gradients on fast gradient echo imaging , 1994, Magnetic resonance in medicine.

[7]  A. Wiethoff,et al.  Initial imaging recommendations for Vasovist angiography , 2006, European radiology.

[8]  S. Schoenberg,et al.  Practical approaches to the evaluation of signal‐to‐noise ratio performance with parallel imaging: Application with cardiac imaging and a 32‐channel cardiac coil , 2005, Magnetic resonance in medicine.

[9]  Peter Boesiger,et al.  Sensitivity encoding as a means of enhancing the SNR efficiency in steady‐state MRI , 2005, Magnetic Resonance in Medicine.

[10]  P. Boesiger,et al.  SENSE: Sensitivity encoding for fast MRI , 1999, Magnetic resonance in medicine.

[11]  E Kent Yucel,et al.  MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. , 2005, Radiology.

[12]  R. Dolan,et al.  MS-325: albumin-targeted contrast agent for MR angiography. , 1998, Radiology.

[13]  A de Roos,et al.  Blood pool contrast agents for cardiovascular MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.

[14]  M R Prince,et al.  Optimizing three-dimensional gadolinium-enhanced magnetic resonance angiography. Original investigation. , 1998, Investigative radiology.

[15]  C. Higgins,et al.  Blood pool MR contrast agents for cardiovascular imaging , 2000, Journal of magnetic resonance imaging : JMRI.